SCHEMBL6578064

SCHEMBL6578064

Cc1ccc(N2CCC(C)(C)c3ccc(Br)cc32)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2B P41595 3/20 0.34
HTR7 P34969 2/20 0.34
TMEM97 Q5BJF2 2/20 0.34
SIGMAR1 Q99720 2/20 0.34
ALDH1A1 P00352 2/20 0.33
MAPT P10636 1/20 0.33
PIK3CA P42336 2/20 0.32
SRD5A1 P18405 1/20 0.32
HSD11B1 P28845 1/20 0.32
GABRA1 P14867 1/20 0.32
GABRB2 P47870 1/20 0.32
PDE4B Q07343 1/20 0.32
RORC P51449 1/20 0.31
DHFR P00374 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
NFKB1 P19838 1/20 0.31
HTR2A P28223 1/20 0.31
HTR2C P28335 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6574407 0.87 HSD11B1 (0.42) SIGMAR1ALDH1A1MAPTPIK3CAHSD11B1
SCHEMBL6574397 0.80 RARA (0.37) HTR2BHTR7TMEM97SIGMAR1
SCHEMBL6575696 0.79 RARB (0.46) ALDH1A1RORCCYP1A2CYP3A4CYP2D6
SCHEMBL6575676 0.76 RARB (0.39) PIK3CAGABRA1CYP3A4
SCHEMBL9143502 0.75 GABRA1 (0.38) HTR2BSIGMAR1ALDH1A1GABRA1GABRB2
SCHEMBL6577986 0.73 RARB (0.59) ALDH1A1RORCCYP1A2CYP3A4CYP2D6
SCHEMBL6575669 0.73 RARB (0.59) ALDH1A1RORCCYP1A2CYP3A4CYP2D6
SCHEMBL6578025 0.72 RARB (0.65) CYP3A4
SCHEMBL7712301 0.72 RARA (0.53) HTR2BSIGMAR1HSD11B1GABRA1GABRB2
SCHEMBL6578039 0.71 RXRA (0.43) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0937045-B1 N-ARYL SUBSTITUTED TETRAHYDROQUINOLINES LIGANDS FOR RETINOID RECEPTORS HAVING AGONIST, ANTAGONIST OR INVERSE AGONIST TYPE ACTIVITY ALLERGAN INC (US) 2004-04-28 EP disclosed
EP-0937045-A1 N-ARYL SUBSTITUTED TETRAHYDROQUINOLINES LIGANDS FOR RETINOID RECEPTORS HAVING AGONIST, ANTAGONIST OR INVERSE AGONIST TYPE ACTIVITY Allergan Sales, Inc. (US) 1999-08-25 EP disclosed
WO-1998019999-A1 N-ARYL SUBSTITUTED TETRAHYDROQUINOLINES LIGANDS FOR RETINOID RECEPTORS HAVING AGONIST, ANTAGONIST OR INVERSE AGONIST TYPE ACTIVITY ALLERGAN SALES, INC. (US) 1998-05-14 WO disclosed
US-5739338-A SKIN DISORDERS, ANTIINFLAMMATORY AGENTS, ANTITUMOR AGENTS, VISION DEFECTS, VIRICIDES, IMMUNOSUPPRESSANTS ALLERGAN (US) 1998-04-14 US disclosed